health

The Global Fund will roll out the twice-yearly anti-HIV jab — with or without Pepfar - Bhekisisa

The major backer of the lenacapavir roll-out is assuring nervous researchers that they will keep their part of funding promises. It’s a good economic investment, says the Fund’s Peter Sands, into a game-changing drug that could save millions of lives.

By:Ida Jooste, Ida Jooste
Source:Bhekisisa.org
Published:
The Global Fund will roll out the twice-yearly anti-HIV jab — with or without Pepfar - Bhekisisa
  • That would be unwise, some experts say, especially if the Global Funds investment case is anything to go by.
In today’s newsletter, Mia Malan explains how the twice-yearly HIV prev… [+10022 chars]

Related News